Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
39
TBPH Quote, Financials, Valuation and Earnings
Last price:
$11.61
Seasonality move
:
-3.18%
Day range:
$11.56 - $11.88
52-week range:
$7.44 - $11.82
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.78x
P/B ratio:
3.51x
Volume:
199.5K
Avg. volume:
226.8K
1-year change:
17.49%
Market cap:
$582.5M
Revenue:
$64.4M
EPS (TTM):
-$1.18
Earnings Data
Next earnings date for TBPH
Aug 05
2025
Most recent earnings per share
-$0.27
Missed by $0.18
(May 8/2025)
Consensus Estimate
-$0.09
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TBPH Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $19.1M | -- | -- | -$0.09 | -- |
| 08/05/2025 | Q2 | $26M | -- | -- | -$0.13 | -- |
| 05/08/2025 | Q1 | $15.6M | $15.4M | -$0.27 | -$0.09 | -$0.18 |
| 02/26/2025 | Q4 | $17.1M | $18.8M | -$0.31 | -$0.08 | -$0.23 |
| 11/12/2024 | Q3 | $15.4M | $16.9M | -$0.26 | -$0.10 | -$0.16 |
| 08/05/2024 | Q2 | $15.3M | $14.3M | -$0.34 | -$0.07 | -$0.27 |
| 05/13/2024 | Q1 | $14M | $14.5M | -$0.24 | -$0.12 | -$0.12 |
| 02/26/2024 | Q4 | $17.6M | $17.6M | -$0.17 | -$0.00 | -$0.17 |
| 11/07/2023 | Q3 | -- | -- | -$0.17 | -$0.10 | -$0.08 |
| 08/07/2023 | Q2 | -- | -- | -$0.28 | -$0.11 | -$0.17 |
| 05/08/2023 | Q1 | -- | -- | -$0.35 | -$0.20 | -$0.15 |
| 02/27/2023 | Q4 | -- | -- | -$0.15 | -$0.07 | -$0.08 |
| 11/30/2022 | Q4 | -- | -- | $0.01 | -- | -- |
| 11/07/2022 | Q3 | -- | -- | $12.14 | -$0.04 | $12.18 |
| 08/04/2022 | Q2 | -- | -- | -$0.11 | $0.15 | -$0.26 |
| 05/05/2022 | Q1 | -- | -- | -$0.34 | $0.10 | -$0.44 |
| 02/23/2022 | Q4 | -- | -- | -$0.43 | -$0.19 | -$0.24 |
| 11/03/2021 | Q3 | -- | -- | -$0.48 | -$0.52 | $0.04 |
| 08/03/2021 | Q2 | -- | -- | -$0.80 | -$0.88 | $0.08 |
| 05/04/2021 | Q1 | -- | -- | -$1.24 | -$0.80 | -$0.45 |
| 02/23/2021 | Q4 | -- | -- | -$0.92 | -$0.82 | -$0.10 |
| 11/05/2020 | Q3 | -- | -- | -$1.16 | -$0.88 | -$0.28 |
| 08/06/2020 | Q2 | -- | -- | -$1.00 | -$0.88 | -$0.12 |
| 05/07/2020 | Q1 | -- | -- | -$1.40 | -$1.00 | -$0.40 |
| 02/24/2020 | Q4 | -- | -- | -$1.17 | -$1.11 | -$0.06 |
| 11/05/2019 | Q3 | -- | -- | -$1.05 | -$1.11 | $0.06 |
| 07/31/2019 | Q2 | -- | -- | -$0.72 | -$1.24 | $0.52 |
| 05/07/2019 | Q1 | -- | -- | -$1.32 | -$1.20 | -$0.13 |
| 02/26/2019 | Q4 | -- | -- | -$0.92 | -$1.00 | $0.08 |
| 11/06/2018 | Q3 | -- | -- | -$1.10 | -$1.14 | $0.04 |
| 08/01/2018 | Q2 | -- | -- | -$0.76 | -$1.23 | $0.47 |
| 05/08/2018 | Q1 | -- | -- | -$1.22 | -$1.36 | $0.14 |
| 02/27/2018 | Q4 | -- | -- | -$1.64 | -$1.18 | -$0.46 |
| 11/07/2017 | Q3 | -- | -- | -$1.27 | -$1.14 | -$0.13 |
| 08/08/2017 | Q2 | -- | -- | -$1.27 | -$1.18 | -$0.10 |
| 05/08/2017 | Q1 | -- | -- | -$1.27 | -$1.18 | -$0.09 |
| 02/27/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/08/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/08/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -- | -- | -- |
| 03/09/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -- | -- | -- |
Theravance Biopharma Earnings Questions
-
How Much did Theravance Biopharma Generate in Revenue Last Quarter?
Theravance Biopharma reported $15.4M worth of top line sales in its most recent quarter.
-
Did Theravance Biopharma Beat Earnings Last Quarter?
Theravance Biopharma announced earnings per share of -$0.27 which represents a miss of analyst forecast a -$0.09 per share.
-
Is Theravance Biopharma Profitable?
Theravance Biopharma reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Theravance Biopharma EPS Next Year?
Theravance Biopharma's earnings are forecast to decrease from -$1.15 per share to -$0.42 per share next year representing a decrease of -57.67%.
-
When is Theravance Biopharma's Earnings Date?
Theravance Biopharma's next earnings date is August 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
